Recently it was suggested that substitution in codon 790 of exon 20 EGFR gene could be visible primary in coincidence with other activating mutations of EGFR gene (5–30 % NSCLC patients) [4–6] and secondary, after primary EGFR disorders, mainly L858R mutation (app. Here, EGFR is linked to non-small cell lung carcinoma.